Exploration, Innovation and Creativity: An intimate look at new drug development in the world of pituitary and neuroendocrine disease

This is the first in a series of 6 podcasts on the ins and outs of drug development.  In it, we discuss the journey that a promising molecule takes to develop into a life-saving medication and the people that steer that rigorous work.  How does a company go from a molecule to the actual medication? What are the steps? Who is involved? What are the processes and barriers?  And what does that process look like in real-time?  Thanks to a kind invitation from Dr. Scott Struthers, chairman of Crinetics Pharmaceutical and his team, PWN readers and listeners will get an unfettered look at a young company’s efforts to develop new drugs to solve unmet needs in acromegaly, Cushing’s and rare neuroendocrine disease.  Don’t miss it!

 

Photo by Pixabay

© 2020, Pituitary World News. All rights reserved.

LEAVE A REPLY

Please enter your comment!
Please enter your name here